Get started
RocketTickers

TRACON Pharmaceuticals Announces FDA Approval of Amended ENVASAR

Long
TRACON Pharmaceuticals, Inc. (NASDAQ:TCON)  
RocketTickers  
NASDAQ:TCON   TRACON Pharmaceuticals, Inc.
Beyond Technical Analysis
1
1
beyondta
TCON: TRACON Pharmaceuticals, Inc.
2022-03-10 08:05:00
TRACON Pharmaceuticals Announces FDA Approval of Amended ENVASARC Protocol
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.